NEW YORK–(Company WIRE)– Pfizer Inc. (NYSE: PFE) nowadays announced that David M. Denton will be a part of the Organization as Main Economic Officer (CFO) and Executive Vice President powerful May possibly 2, 2022. Mr. Denton will be a member of Pfizer’s Government Management Staff reporting to Chairman and Chief Government Officer, Albert Bourla. He joins Pfizer from Lowe’s Providers, Inc. exactly where he served as CFO and Executive Vice President. Mr. Denton succeeds Frank D’Amelio, CFO and Executive Vice President, who not long ago introduced his intention to depart Pfizer soon after a noteworthy 15-12 months career. Mr. D’Amelio has agreed to stay in spot via a changeover time period.
Mr. Denton has extra than 25 yrs of finance and operational know-how, including additional than 20 many years in the healthcare sector. As a end result, he provides to Pfizer a exceptional perspective on the purpose of payers, the demands of people, and the quickly evolving health care landscape.
At Pfizer, Mr. Denton will be a key considered lover to the Company’s CEO and Government Leadership Workforce even though overseeing each individual facet of the Company’s fiscal administration. He will be liable for all company finance features, together with audit, treasury, tax, insurance, operations planning and analysis (OP&A), company controllership, and company finance and analytics.
“Our Firm’s continued financial power is crucial to Pfizer’s capability to produce on our function and to build extensive-expression benefit for all our stakeholders,” claimed Albert Bourla, Chairman and Main Executive Officer, Pfizer. “Dave brings with him deep economic working experience, a observe file of achievement and real insights into today’s health care method. For these motives, he is the best chief to consider the helm of our talented finance group and deliver a comprehensive strategic economical vision that will help generate Pfizer’s upcoming development and results.”
Bourla ongoing, “My sincere thanks to Frank D’Amelio for his several and long lasting contributions to Pfizer, together with mentoring so many of Pfizer’s latest fantastic leaders and improving upon the lives of so many clients all over the entire world.”
“We are residing at a time of unprecedented scientific progression and Pfizer is a enterprise that is unparalleled in its ambition to make a difference in patients’ lives. For me, there could be no expert option increased than leveraging all my decades of finance and enterprise practical experience to perform a function in assisting deliver on this aspiration, operating alongside a significant-carrying out staff that has been crafted for advancement and boosting shareholder returns,” said David Denton.
Prior to signing up for Lowe’s in 2018, Mr. Denton served as Executive Vice President and CFO of CVS Health, wherever he was accountable for all elements of their economic preparing and administration. He played a key purpose in CVS’s transformational journey from a retail pharmacy to the wellness remedies corporation it is these days and led the whole integration of Caremark into CVS. In December 2017, Mr. Denton performed a pivotal purpose in CVS’s acquisition of Aetna, structuring and negotiating the terms and funding for the transaction.
Just before becoming CFO at CVS, Mr. Denton held many management roles, together with senior vice president and controller/chief accounting officer. Prior to CVS, he was with the management consulting agency of Deloitte Touche Tohmatsu.
He acquired a bachelor’s diploma in company administration from Kansas State University, United states of america and an MBA from the Babcock Graduate College of Administration at Wake Forest College, Usa. He serves on the board of Tapestry, Inc.
About Pfizer: Breakthroughs That Modify Patients’ Lives
At Pfizer, we implement science and our world-wide methods to carry therapies to persons that lengthen and drastically increase their life. We attempt to set the regular for good quality, protection and price in the discovery, development and manufacture of wellbeing care merchandise, such as innovative medications and vaccines. Each and every working day, Pfizer colleagues get the job done across made and emerging markets to advance wellness, prevention, treatment plans and cures that obstacle the most feared illnesses of our time. Steady with our duty as 1 of the world’s leading revolutionary biopharmaceutical businesses, we collaborate with health and fitness care suppliers, governments and regional communities to help and extend obtain to reliable, economical health and fitness treatment close to the environment. For a lot more than 170 several years, we have worked to make a distinction for all who depend on us. We routinely publish details that may be essential to traders on our internet site at www.Pfizer.com. In addition, to find out additional, please take a look at us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Fb at Fb.com/Pfizer.
Disclosure Observe:The info contained in this release is as of April 11, 2022. The Organization assumes no obligation to update ahead-hunting statements contained in this launch as a end result of new information or long term activities or developments.
This release includes forward-searching data about, among the other items, the Company’s price creation and advancement likely that are topic to sizeable pitfalls and uncertainties that could bring about real outcomes to differ materially from people expressed or implied by these types of statements. Dangers and uncertainties consist of, between other matters, the uncertainties inherent in analysis and progress the uncertainties inherent in business enterprise and money arranging, together with, without having limitation, dangers connected to Pfizer’s organization and prospects, adverse developments in Pfizer’s marketplaces, or adverse developments in the U.S. or world-wide capital markets, credit rating markets, regulatory atmosphere or economies typically the influence of COVID-19 on our small business, functions and money results and competitive developments.
A even further description of challenges and uncertainties can be uncovered in Pfizer’s Yearly Report on Form 10-K for the fiscal yr finished December 31, 2021 and in its subsequent experiences on Sort 10-Q, which includes in the sections thereof captioned “Risk Factors” and “Forward-Seeking Details and Aspects That May perhaps Have an effect on Potential Results”, as very well as in its subsequent stories on Type 8-K, all of which are submitted with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.
+1 (212) 733-1226
+1 (212) 733-4848
Resource: Pfizer Inc.